Compare LXEO & FWDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXEO | FWDI |
|---|---|---|
| Founded | 2017 | 1961 |
| Country | United States | United States |
| Employees | N/A | 60 |
| Industry | | Plastic Products |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.9M | 423.2M |
| IPO Year | 2023 | N/A |
| Metric | LXEO | FWDI |
|---|---|---|
| Price | $6.53 | $4.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.44 | N/A |
| AVG Volume (30 Days) | ★ 807.3K | 778.4K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $654,000.00 | N/A |
| Revenue This Year | N/A | $407.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.43 | $4.06 |
| 52 Week High | $10.99 | $9.28 |
| Indicator | LXEO | FWDI |
|---|---|---|
| Relative Strength Index (RSI) | 52.84 | 53.93 |
| Support Level | $6.15 | $4.53 |
| Resistance Level | $7.77 | $5.75 |
| Average True Range (ATR) | 0.46 | 0.24 |
| MACD | 0.13 | 0.07 |
| Stochastic Oscillator | 72.58 | 80.00 |
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Forward Industries Inc is a provider of carrying and protective solutions. The company operates in two segments: design and digital assets. The design segment consists of two operating segments (IPS and Kablooe, which have been aggregated into one reportable segment) that provide a full spectrum of hardware and software product design and engineering services to customers predominantly.